Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer

BACKGROUND: Endometrial cancer (EC) is a common gynecologic malignancy and patients with advanced and recurrent EC have a poor prognosis. Although chemotherapy is administered for those patients, the efficacy of current chemotherapy is limited. Therefore, it is necessary to develop novel therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagase, Yoshikazu, Hiramatsu, Kosuke, Funauchi, Masashi, Shiomi, Mayu, Masuda, Tatsuo, Kakuda, Mamoru, Nakagawa, Satoshi, Miyoshi, Ai, Matsuzaki, Shinya, Kobayashi, Eiji, Kimura, Toshihiro, Serada, Satoshi, Ueda, Yutaka, Naka, Tetsuji, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210735/
https://www.ncbi.nlm.nih.gov/pubmed/35729527
http://dx.doi.org/10.1186/s12885-022-09789-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210735/
https://www.ncbi.nlm.nih.gov/pubmed/35729527
http://dx.doi.org/10.1186/s12885-022-09789-6

Ejemplares similares